Author

Sriram S Shanmugavelandy

Abbvie - Cited by 1,538 - Cancer Biology Nano technology

Biography

Sriram S Shanmugavelandy is a well-known researcher working in Department of Pharmacology, Penn State College of Medicine, Hershey, USA and has extended valuable service for many years and has been a recipient of many awards and grants.  
Title
Cited by
Year
Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery
TT Morgan, HS Muddana, EI Altinoglu, SM Rouse, A Tabakovic, ...Nano letters 8 (12), 4108-4115, 2008200
331
2008
Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia
BM Barth, E I. Altinoğlu, SS Shanmugavelandy, JM Kaiser, ...ACS nano 5 (7), 5325-5337, 2011201
167
2011
Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo
BM Barth, R Sharma, EI Altınogˇlu, TT Morgan, SS Shanmugavelandy, ...ACS nano 4 (3), 1279-1287, 2010201
148
2010
Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia
X Liu, L Ryland, J Yang, A Liao, C Aliaga, R Watts, SF Tan, J Kaiser, ...Blood, The Journal of the American Society of Hematology 116 (20), 4192-4201, 2010201
105
2010
Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models
PP Adiseshaiah, JD Clogston, CB McLeland, J Rodriguez, TM Potter, ...Cancer letters 337 (2), 254-265, 2013201
78
2013
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer
Y Jiang, NA DiVittore, JM Kaiser, SS Shanmugavelandy, JL Fritz, ...Cancer biology & therapy 12 (7), 574-585, 2011201
70
2011
Metabolic differences in glutamine utilization lead to metabolic vulnerabilities in prostate cancer
NM Zacharias, C McCullough, S Shanmugavelandy, J Lee, Y Lee, P Dutta, ...Scientific reports 7 (1), 16159, 2017201
69
2017
Ceramide–antiestrogen nanoliposomal combinations—novel impact of hormonal therapy in hormone-insensitive breast cancer
SAF Morad, JC Levin, SS Shanmugavelandy, M Kester, G Fabrias, ...Molecular cancer therapeutics 11 (11), 2352-2361, 2012201
51
2012
Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU
CL Kline, SS Shanmugavelandy, M Kester, RB IrbyCancer biology & therapy 8 (19), 1831-1837, 2009200
50
2009
Nanoliposomal minocycline for ocular drug delivery
JM Kaiser, H Imai, JK Haakenson, RM Brucklacher, TE Fox, ...Nanomedicine: Nanotechnology, Biology and Medicine 9 (1), 130-140, 2013201
48
2013
Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53
SAF Morad, JP Madigan, JC Levin, N Abdelmageed, R Karimi, ...Biochemical pharmacology 85 (8), 1057-1065, 2013201
47
2013
Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance
BM Barth, SJ Gustafson, MM Young, TE Fox, SS Shanmugavelandy, ...Cancer biology & therapy 10 (11), 1126-1136, 2010201
39
2010
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia
LK Ryland, UA Doshi, SS Shanmugavelandy, TE Fox, C Aliaga, K Broeg, ...PLoS One 8 (12), e84648, 2013201
39
2013
Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia
RJ Watters, TE Fox, SF Tan, S Shanmugavelandy, JE Choby, K Broeg, ...Leukemia & lymphoma 54 (6), 1288-1296, 2013201
38
2013
PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate
BM Barth, SS Shanmugavelandy, JM Kaiser, C McGovern, EI Altınoğlu, ...ACS nano 7 (3), 2132-2144, 2013201
38
2013
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
BM Barth, W Wang, PT Toran, TE Fox, C Annageldiyev, RM Ondrasik, ...Blood advances 3 (17), 2598-2603, 2019201
28
2019
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo
N Zacharias, J Lee, S Ramachandran, S Shanmugavelandy, J McHenry, ...Molecular Imaging and Biology , 86-94, 2019201
21
2019
Assessing metabolic intervention with a glutaminase inhibitor in real-time by hyperpolarized magnetic resonance in acute myeloid leukemia
NM Zacharias, N Baran, SS Shanmugavelandy, J Lee, JV Lujan, P Dutta, ...Molecular cancer therapeutics 18 (11), 1937-1946, 191
20
2019
Calcium phosphosilicate nanoparticles for imaging and photodynamic therapy of cancer
DM Tacelosky, AE Creecy, SS Shanmugavelandy, JP Smith, DF Claxton, ...Discovery medicine 13 (71), 275-285, 2012201
15
2012
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ...Nature communications 13 (1), 2801, 2022202
14
2022

Referred From: https://scholar.google.com/citations?user=Rj0Dj6UAAAAJ&hl=en

Cited by
Citations 1538
h-index 19
i10-index 25
Recommended Journals
Open Access Journals